Mesalamine Suspension
Product Images NDC 84725-002

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 84725-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Klm Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cart-label (Cart Label)

Packaging label for Mesalamine Rectal Suspension, USP Enema 4 g/60 mL by KLM Laboratories Private Limited. This 7-pack contains seven 60 mL unit-dose bottles. The label includes dosage information, storage instructions, and warnings such as shaking well before use and keeping medication out of children's reach. The NDC is 84725-002-04.*

FDA Label Image

Cont-label (Cont Label)

The label for Mesalamine Rectal Suspension, USP Enema 4 g/60 mL by KLM Laboratories Private Limited. It states the product is for rectal use only, contains 60 mL per unit-dose, and is prescription only. The label includes storage instructions, a list of inactive ingredients, and distributor information for One2Zee LLC.*

FDA Label Image

Fig-a (Fig A)

An instructional line drawing labeled 'Figure A' showing a hand holding a rectangular sachet or pouch while another hand uses scissors to cut the top edge open. The illustration likely demonstrates how to open the packaging of a liquid or suspension product.*

FDA Label Image

Fig-b (Fig B)

Illustration showing two hands holding parts of a rectal suspension applicator. The left hand holds the protective sheath, and the right hand holds the applicator tip and nozzle. The figure is labeled as Figure B.*

FDA Label Image

Fig-c (Fig C)

Illustration labeled Figure C showing a person lying on their left side with right leg bent and left leg extended, demonstrating a recommended position for rectal administration of medication.*

FDA Label Image

Fig-d (Fig D)

An instructional illustration showing a person in a kneeling and leaning forward position, likely to demonstrate the recommended posture for rectal administration of medication, such as Mesalamine suspension.*

FDA Label Image

Fig-e (Fig E)

An instructional line drawing labeled Figure E depicting a hand administering a rectal suspension using a small nozzle or applicator, showing the method of delivering liquid medication rectally.*

FDA Label Image

Structure (Structure)

Chemical structure of mesalamine, showing a benzene ring with amino (NH2), carboxyl (COOH), and hydroxyl (OH) functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.